Alloy Therapeutics hires Krishnamurthy as CSO — SkimNews
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Alloy Therapeutics hired Venkat Krishnamurthy as chief scientific officer of its genetic medicines division
- Krishnamurthy previously held the same CSO role at Flashpoint Therapeutics, signaling continued demand for his genetic-medicines leadership
- STAT+ publishes this as a recurring weekly feature spotlighting a single executive move per edition, with the rest of the article devoted to soliciting reader submissions
Why it matters: Krishnamurthy's move from one genetic-medicines-focused startup to another in the identical CSO seat suggests Alloy Therapeutics is betting on continuity of his niche expertise, while the surrounding copy reveals STAT is essentially crowd-sourcing the column from its readership.
Ask SkimNews